Research is a major component of Butler Hospital’s Movements Disorders Program. In addition to researching the sensory motor symptoms, the behavioral aspects of Parkinson's disease, such as the depression, apathy and fatigue are being studied through multicenter trials sponsored by the National Institutes of Health and the Michael J. Fox Foundation.
Current research studies at Butler related to Parkinson’s disease and other movement disorders include:
Oral Inosine to assess safety and ability to elevate urate in early Parkison’s disease (SURE-PD)
Pimavanserin in the Treatment of Psychosis in Parkinson’s disease
Safinamide as and add-on therapy in Parkinson’s disease patients treated with a dopamine agonist
The Effects of Co-Enzyme Q10 in Parkinson’s disease
If you are interested in participating in a movement disorders research trial, please call (401) 455-6669.